Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Kendle 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Kendle 3Q

Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 3Q09

3Q Revenues: $133.8 million (-26%)

3Q Earnings: $8.8 million (-6%)

YTD Revenues: $421.0 million (-19%)

YTD Earnings: $12.9 million (-35%)

Comments: Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%). Late Stage revenue was down 17% to $91.5 million in the quarter and down 14% to $284.7 million YTD. New business awards for the quarter totaled $137.2 million, up from $132 million in 2Q09. Contract cancellations for the quarter were $53.8 million or 6% of the company’s backlog at June 30, 2009.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters